Pharmally’s Krizle Mago now under House protective custody - Aglipay | Inquirer News

Pharmally’s Krizle Mago now under House protective custody – Aglipay

/ 06:59 PM October 01, 2021

Pharmally official Krizle Grace Mago. (Photo from the House of Representatives)

MANILA, Philippines — Krizle Grace Mago, the Pharmally Pharmaceutical Corp. official who dropped damning revelations about changing expiration dates of face shields and who went missing after her testimony, is now under the protective custody of the House of Representatives.

Rep. Michael Edgar Aglipay, chair of the committee on good government and public accountability, said Mago is now in a secure location within the House complex.


“We have taken protective custody of Kristle Mago at exactly 6:30 p.m. She is now safely inside the HOR.  All questions should be directed to the Sgt-at-arms Mao Aplasca,” Aglipay said. has tried to contact House Sergeant-at-Arms and former police general Mao Aplasca to confirm Mago’s presence at the House, but he has not yet replied as of posting time.


However, the House of Representatives showed a photo of Mago inside an unidentified office.

According to Mago, she sought for protective custody from the House because she believes she cannot speak freely on the issue without “feeling threatened” by various individuals.

“Presently, I cannot speak freely about the ongoing investigation on the alleged overprice of medical equipments (sic) without feeling threatened due to the undue influence and pressure being exerted from various sources,” she said.

“I feel that my life and liberty is in grave danger because of my coming out and desire to speak the truth.  Also now, I came across the information from the news that the police and NBI are tracking me down including my grandparents’ home in the province and took photos and videos without their consent.  I truly regret that I am being treated like a fugitive from justice,” she added.

Mago said that the protective custody by the House would help her speak freely.

“The protective custody that I am requesting from the HOR would help me speak freely without unnecessary compulsion from anyone,” she said.

During the Senate blue ribbon committee hearing last week, a person who claimed to work with Pharmally was presented by Senator Risa Hontiveros.  The witness claimed that Mago ordered them to change the expiry dates on the face shields supplied to the government.


Mago conceded it was true.

Senate leaders offered some protection to her, but they could not contact her in the days and weeks that followed.  The Senate then requested assistance from the National Bureau of Investigation in finding Mago.

READ: Mago ‘incommunicado’ since damning testimony vs Pharmally 

READ: Senate panel taps NBI to help locate Pharmally’s Mago 

Mago’s revelation came during the Senate committee hearing on the Commission on Audit (COA) report, which showed P67.32 billion worth of deficiencies in the Department of Health (DOH) COVID-19 funds.

Part of that was the P42 billion funds transferred by the DOH to procuring agencies like the Procurement Service of the Department of Budget and Management, which awarded the P8.7 billion supplies contract to Pharmally despite the firm’s small paid-up capital of P625,000.

READ: P8.7-B med supply deals went to tiny company

Aglipay’s committee is also conducting its own probe on the issue.


Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: House committee on good government and public accountability, Krizle Grace Mago, Pharmally Pharmaceutical Corp., Senate blue ribbon committee
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.